|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.880 CAD | -1.37% |
|
-1.37% | -25.19% |
| 06-15 | XORTX Therapeutics Appoints Mika Grasso as Co-CEO; Voluntarily Delisting from the TSX Venture Exchange | MT |
| 06-15 | Xortx Therapeutics Appoints Mika Grasso as Co-CEO; Provides Gout Drug Update | MT |
| Market Cap | 3.51M 2.49M 2.17M 2.01M 1.85M 237M 3.57M 23.96M 9.41M 117M 9.33M 9.13M 401M | P/E 2024 |
-1.02x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.69M 1.9M 1.66M 1.53M 1.42M 181M 2.73M 18.32M 7.19M 89.28M 7.13M 6.98M 307M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
91.78% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.37% | ||
| 1 week | -1.37% | ||
| Current month | -10.00% | ||
| 1 month | -10.00% | ||
| 3 months | -15.79% | ||
| 6 months | -28.00% | ||
| Current year | -25.19% |
| 1 week | 2.88 |  | 2.93 |
| 1 month | 2.88 | | 3.2 |
| Current year | 2.42 | | 4.83 |
| 1 year | 2.42 | | 9.85 |
| 3 years | 2.42 | | 49.95 |
| 5 years | 2.42 | | 449.05 |
| 10 years | 2.42 | | 449.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mika Grasso
CEO | Chief Executive Officer | 28 | 2026-06-14 |
Allen Davidoff
CEO | Chief Executive Officer | 66 | 2018-01-08 |
Michael Bumby
DFI | Director of Finance/CFO | 62 | 2024-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Davidoff
BRD | Director/Board Member | 66 | 2018-01-08 |
| Chairman | 69 | 2022-06-02 | |
George Scorsis
BRD | Director/Board Member | 50 | 2026-03-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-01 | Other | Director | 0 | 0% | ||
| 02-01 | Option | Director | 20,000 | 0.2873% | ||
| 01-06 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -1.37% | -55.35% | -92.00% | 3.52M | |
| +1.84% | -0.66% | +59.82% | +94.48% | 54.88B | |
| +0.13% | -5.93% | +56.91% | +129.88% | 54.63B | |
| -2.24% | +3.59% | +17.75% | +469.23% | 25.06B | |
| -1.60% | -6.21% | -18.96% | -16.06% | 23.14B | |
| -1.69% | -1.27% | +39.51% | -8.30% | 19.87B | |
| +0.31% | +2.57% | +36.63% | -27.54% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +364.56% | 16.5B | |
| -2.42% | -3.72% | +47.02% | +635.77% | 15.75B | |
| -1.05% | +1.16% | +25.95% | +191.69% | 14.2B | |
| Average | -1.28% | -1.25% | +40.44% | +174.17% | 24.16B | |
| Weighted average by Cap. | -0.53% | -1.45% | +50.32% | +172.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -3.31M -2.34M -2.05M -1.89M -1.75M -223M -3.37M -22.59M -8.87M -110M -8.8M -8.61M -379M | -2.66M -1.88M -1.64M -1.52M -1.4M -179M -2.7M -18.11M -7.11M -88.27M -7.05M -6.9M -303M |
| Net Debt | -2.43M -1.72M -1.51M -1.39M -1.28M -164M -2.48M -16.6M -6.52M -80.91M -6.47M -6.33M -278M | -827K -585K -512K -472K -436K -55.8M -841K -5.64M -2.21M -27.49M -2.2M -2.15M -94.5M |
Employees
-
| Date | Price | Change | Volume |
|---|
Annual profits - Rate of surprise
- Stock Market
- Stocks
- XRTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
